These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29547182)

  • 1. Commentary: Theranostics for stroke: Precision medicine is about tailoring therapy to the mechanism of ischemia.
    Liebeskind DS
    Neurol India; 2018; 66(2):526-528. PubMed ID: 29547182
    [No Abstract]   [Full Text] [Related]  

  • 2. Mapping the collaterome for precision cerebrovascular health: Theranostics in the continuum of stroke and dementia.
    Liebeskind DS
    J Cereb Blood Flow Metab; 2018 Sep; 38(9):1449-1460. PubMed ID: 28555527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostics and precision medicine special feature.
    Navalkissoor S; Gnanasegaran G; Baum R
    Br J Radiol; 2018 Nov; 91(1091):20189004. PubMed ID: 30346232
    [No Abstract]   [Full Text] [Related]  

  • 4. Invited Commentary: Nuclear Theranostics-The Path Forward.
    Greenspan BS; Jadvar H
    Radiographics; 2020 Oct; 40(6):1741-1742. PubMed ID: 33016813
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultrasound-based nanomedicine for molecular imaging of prostate cancer: from diagnostics to theranostics.
    Zhu Y; Sun Y; Duan Y; Chen Y
    Nanomedicine (Lond); 2021 Oct; 16(23):2029-2032. PubMed ID: 34519535
    [No Abstract]   [Full Text] [Related]  

  • 6. Nuclear medicine theranostics comes of age.
    Herrmann K; Kraus BJ; Hadaschik B; Kunikowska J; van Poppel H; N'Dow J; Sartor O; Oyen WJG
    Lancet Oncol; 2021 Nov; 22(11):1497-1498. PubMed ID: 34735807
    [No Abstract]   [Full Text] [Related]  

  • 7. The ICPO Foundation-on the way toward collaborative growth of theranostics.
    Baum RP; Mailman J; Jaume O
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):443-444. PubMed ID: 34984500
    [No Abstract]   [Full Text] [Related]  

  • 8. Not All Gatekeepers Are Theranostics.
    Bailey DL
    J Nucl Med; 2023 Oct; 64(10):1662. PubMed ID: 37385672
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to: Not All Gatekeepers Are Theranostics.
    Weber WA; Barthel H; Bengel FM; Eiber MM; Herrmann K; Schäfers M
    J Nucl Med; 2023 Oct; 64(10):1662-1663. PubMed ID: 37385669
    [No Abstract]   [Full Text] [Related]  

  • 10. PET in the Era of Theranostics. Preface.
    Ahmadzadehfar H; Gholamrezanezhad A
    PET Clin; 2021 Jul; 16(3):xv-xvi. PubMed ID: 34053588
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to "Theranostics Is Not Radiotheranostics".
    Weber WA
    J Nucl Med; 2023 Dec; 64(12):2002. PubMed ID: 37857507
    [No Abstract]   [Full Text] [Related]  

  • 12. What Is Theranostics?
    Weber WA; Barthel H; Bengel F; Eiber M; Herrmann K; Schäfers M
    J Nucl Med; 2023 May; 64(5):669-670. PubMed ID: 37055220
    [No Abstract]   [Full Text] [Related]  

  • 13. Theranostics Is Not Radiotheranostics.
    Wei W
    J Nucl Med; 2023 Dec; 64(12):2002. PubMed ID: 37857506
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular imaging for better theranostics.
    Jiang D; Wei W
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3799-3801. PubMed ID: 37646834
    [No Abstract]   [Full Text] [Related]  

  • 15. Theranostics approach in drug development: is there study efficiency when the prevalence of the molecular target is very high?
    Wang SJ; Fotenos A; Masters SC; Marzella L
    Theranostics; 2022; 12(7):3079-3083. PubMed ID: 35547778
    [No Abstract]   [Full Text] [Related]  

  • 16. Rational Design of Biomolecular Templates for Synthesizing Multifunctional Noble Metal Nanoclusters toward Personalized Theranostic Applications.
    Yu Y; Mok BY; Loh XJ; Tan YN
    Adv Healthc Mater; 2016 Aug; 5(15):1844-59. PubMed ID: 27377035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-Instructed Self-assembly in Biological Milieu for Theranostics Purpose.
    Huang Z; Yao Q; Wei S; Chen J; Gao Y
    Curr Med Chem; 2019; 26(8):1351-1365. PubMed ID: 28933284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrates Matter for Personalized Medicine: The Birth of Glyco-Theranostics.
    Özdemir V
    OMICS; 2020 Jan; 24(1):1-2. PubMed ID: 31855503
    [No Abstract]   [Full Text] [Related]  

  • 19. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Advances of Drugs for Cancer Theranostics - PART-IV.
    Feng LS
    Curr Top Med Chem; 2021; 21(18):1644. PubMed ID: 34726135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.